Regenxbio (RGNX) Other Non Operating Income (2014 - 2025)

Regenxbio's Other Non Operating Income history runs 11 years deep, the most recent figure standing at $18000.0 for Q4 2025.

• On a quarterly basis, Other Non Operating Income fell 78.31% year-over-year to $18000.0 in Q4 2025; TTM through Dec 2025 was $83000.0, a 52.3% decrease from a year earlier, with the FY2025 full-year figure at $83000.0, down 52.3% from the prior year.
• Other Non Operating Income declined to $18000.0 in Q4 2025 per RGNX's latest filing, from $19000.0 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $14.3 million in Q4 2023 and bottomed at $18000.0 in Q3 2022.
• The 5-year median for Other Non Operating Income is $38500.0 (2023), against an average of $787650.0.
• Across the five-year window, Other Non Operating Income soared 18431.17% in 2023 and tumbled 99.42% in 2024, its largest moves.
• Year by year, Other Non Operating Income stood at $19000.0 in 2021, then soared by 305.26% to $77000.0 in 2022, then surged by 18431.17% to $14.3 million in 2023, then tumbled by 99.42% to $83000.0 in 2024, then plunged by 78.31% to $18000.0 in 2025.
• Per Business Quant, the three latest RGNX Other Non Operating Income figures stand at $18000.0 (Q4 2025), $19000.0 (Q3 2025), and $21000.0 (Q2 2025).